NCT04218708Completed
Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS
Source: ClinicalTrials.gov · Last updated 20 Dec 2024
Brief summary (registry, in English)
This is a research study to understand and determine the effectiveness of electronic cigarettes versus nicotine replacement therapy in adults who smoke and also live with HIV/AIDS in effort to reduce cigarette smoking.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 64 (actual)
- First submitted
- 2 Jan 2020
- Start date
- 17 Jun 2021
- Primary completion date
- 15 Dec 2023
- Lead sponsor
- NYU Langone Health
- Diseases
- HIV
- NCT number
- NCT04218708
What you commit to
- Study type: Interventional
- Participants enrolled: 64
- From 17 Jun 2021 to the primary completion date, 15 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- State diagnosis of any medical condition (angina/heart disease) precluding use of nicotine patch or gum, or by self-report in screening questionnaire
- Have untreated/are undergoing current treatment for psychiatric illness or cognitive impairment at time of initial screening as determined by the subjects' primary care doctor or a licensed study team member in screening
- Report a history of severe or untreated cardiopulmonary disease such as asthma or emphysema.
Other
- Are pregnant (as determined by urine test) or breastfeeding (self-reported),
- Reporting using NRTs or e-cigarettes or within the last 30 days
Who the study is looking for
- Current Combustible Cigarette (CC) smokers (more than 5 packs in a lifetime; smokes 4 or more days/week),
- Smokes at least 10 cigarettes per day on days they smoke CC.
- Motivated to quit smoking (at least a 5 on a 10-point Likert scale).
- Must be able to provide consent
- Agree to be randomized and followed-up with,
- Reside in New York City
- Be willing to use an e-cigarette or NRT for 12 weeks.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.